demonstrated that TRIM21, as the ubiquitin E3 ligase for Oct-1, could promote octamer-binding transcription factor 1 (Oct-1) ubiquitination and, consequently, reducing Oct-1 stability; in this way, a positive role played by TRIM21 in deactivating cancer stem cells and reducing treatment resistance [20]. This evidence concerns the gene TRIM21 and cancer.